The Journal of Practical Medicine ›› 2024, Vol. 40 ›› Issue (19): 2801-2805.doi: 10.3969/j.issn.1006-5725.2024.19.023
• Reviews • Previous Articles Next Articles
Xianghong CHEN,Xiumin CHEN,Yingyan ZHOU,Li LI,Zhenxiong. XU()
Received:
2024-04-10
Online:
2024-10-10
Published:
2024-10-22
Contact:
Zhenxiong. XU
E-mail:xuzhenxiongershi@163.com
CLC Number:
Xianghong CHEN,Xiumin CHEN,Yingyan ZHOU,Li LI,Zhenxiong. XU. Advancements in the investigation of cardiovascular risk associated with idiopathic inflammatory myopathy[J]. The Journal of Practical Medicine, 2024, 40(19): 2801-2805.
1 | 中华医学会风湿病学分会. 多发性肌炎和皮肌炎诊断及治疗指南[J]. 中华风湿病学杂志, 2010,14(12): 828-831. |
2 | 邱梦倩, 周蕾. 心肌标志物在评估特发性炎症性肌病心脏损伤中的价值[J]. 心血管病学进展, 2020,41(1): 71-74. |
3 | FAIRLEY J L, WICKS I, PETERS S, et al. Defining cardiac involvement in idiopathic inflammatory myopathies: A systematic review[J]. Rheumatology (Oxford), 2021,61(1): 103-120. |
4 |
SCHWARTZ T, DIEDERICHSEN L P, LUNDBERG I E, et al. Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies[J]. RMD Open, 2016,2(2): e000291. doi:10.1136/rmdopen-2016-000291
doi: 10.1136/rmdopen-2016-000291 |
5 |
JAYAKUMAR D, ZHANG R, WASSERMAN A, et al. Cardiac manifestations in idiopathic inflammatory myopathies: An overview[J]. Cardiol Rev, 2019,27(3): 131-137. doi:10.1097/crd.0000000000000241
doi: 10.1097/crd.0000000000000241 |
6 | 侯英超, 杨建勋. 特发性炎症性肌病相关心血管病变的研究进展[J]. 心血管康复医学杂志, 2023,32(6): 632-635. |
7 |
LIU Y, HSU J, LIU X, et al. Electrophysiological, structural, and functional disorders in patients with inflammatory cardiomyopathy secondary to inflammatory myopathy[J]. Ann Noninvasive Electrocardiol, 2022,27(4): e12938. doi:10.1111/anec.12938
doi: 10.1111/anec.12938 |
8 |
XIONG A, HU Z, ZHOU S, et al. Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies[J]. Rheumatology, 2022,61(7): 2728-2739. doi:10.1093/rheumatology/keab851
doi: 10.1093/rheumatology/keab851 |
9 |
LAZZERINI P E, CAPECCHI P L, EL-SHERIF N, et al. Emerging arrhythmic risk of autoimmune and inflammatory cardiac channelopathies[J]. J Am Heart Assoc, 2018,7(22): e010595. doi:10.1161/jaha.118.010595
doi: 10.1161/jaha.118.010595 |
10 |
NAARAAYAN A, MEREDITH A, NIMKAR A, et al. Arrhythmia prevalence among patients with polymyositis-dermatomyositis in the United States: An observational study[J]. Heart Rhythm, 2021,18(9): 1516-1523. doi:10.1016/j.hrthm.2021.05.029
doi: 10.1016/j.hrthm.2021.05.029 |
11 | ORESKA S, STORKANOVA H, PEKACOVA A, et al. Cardiovascular risk in myositis patients compared with the general population[J]. Rheumatology, (Oxford), 2024,63(3):715-724. |
12 | AMBROSI A, DZIKAITE V, PARK J, et al. Anti-Ro52 monoclonal antibodies specific for amino acid 200-239, but not other Ro52 epitopes, induce congenital heart block in a rat model[J]. Ann Rheum Dis, 2012,71(3): 448-454. |
13 | ALBAYDA J, KHAN A, CASCIOLA-ROSEN L, et al. Inflammatory myopathy associated with anti-mitochondrial antibodies: A distinct phenotype with cardiac involvement[J]. Semin Arthritis Rheum, 2018,47(4): 552-556. |
14 |
HUANG R, ZHANG X, HAN Z, et al. Refractory ventricular tachycardia and heart failure due to anti-mitochondrial antibody-positive inflammatory myopathy[J]. BMC Cardiovasc Disord, 2023,23(1): 57. doi:10.1186/s12872-023-03057-6
doi: 10.1186/s12872-023-03057-6 |
15 |
LIU Y, FANG L, CHEN W, et al. Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies[J]. Cardiovasc Diagn Ther, 2020,10(3): 405-420. doi:10.21037/cdt.2020.03.04
doi: 10.21037/cdt.2020.03.04 |
16 |
MONDAL S, BARMAN P, VIGNESH P. Cardiovascular abnormalities in juvenile dermatomyositis: A scoping review for the clinical rheumatologists[J]. Front Med, 2022,9:827539. doi:10.3389/fmed.2022.827539
doi: 10.3389/fmed.2022.827539 |
17 |
BETTERIDGE Z, TANSLEY S, SHADDICK G, et al. Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients[J]. J Autoimmun, 2019,101: 48-55. doi:10.1016/j.jaut.2019.04.001
doi: 10.1016/j.jaut.2019.04.001 |
18 | ZAMORA E, SEDER-COLOMINA E, HOLGADO S, et al. Heart lung muscle anti-SAE syndrome: An atypical severe combination[J]. J Clin Med, 2018,8(1):20. |
19 |
QUINTERO-GONZÁLEZ D C, NAVARRO-BELEÑO K, LÓPEZ-GUTIÉRREZ L V, et al. Cardiac involvement in anti-MDA5 dermatomyositis: A case-based review[J]. Clin Rheumatol, 2023,42(3): 949-958. doi:10.1007/s10067-022-06401-x
doi: 10.1007/s10067-022-06401-x |
20 |
MATSUO T, SASAI T, NAKASHIMA R, et al. ECG changes through immunosuppressive therapy indicate cardiac abnormality in anti-MDA5 antibody-positive clinically amyopathic dermatomyositis[J]. Front Immunol, 2022,12:765140. doi:10.3389/fimmu.2021.765140
doi: 10.3389/fimmu.2021.765140 |
21 |
ZHOU S, LAI J, WU C, et al. Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: A retrospective study[J]. Front Immunol, 2022,13:928861. doi:10.3389/fimmu.2022.928861
doi: 10.3389/fimmu.2022.928861 |
22 | 王琰. 特发性炎症性肌病相关心脏损害特点分析[D]. 郑州:郑州大学, 2021. |
23 |
WALKER B R. Glucocorticoids and cardiovascular disease[J]. Eur J Endocrinol, 2007,157(5): 545-559. doi:10.1530/eje-07-0455
doi: 10.1530/eje-07-0455 |
24 | DROSOS G C, VEDDER D, HOUBEN E, et al. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome[J]. Ann Rheum Dis, 2022,81(6): 768-779. |
25 |
D'ANDREA E, DESAI R J, HE M, et al. Cardiovascular Risks of hydroxychloroquine vs methotrexate in patients with rheumatoid arthritis[J]. J Am Coll Cardiol, 2022,80(1): 36-46. doi:10.1016/j.jacc.2022.04.039
doi: 10.1016/j.jacc.2022.04.039 |
26 | XIE W, HUANG Y, XIAO S, et al. Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials[J]. Ann Rheum Dis, 2019,78(8): 1048-1054. |
27 |
ATZENI F, POPA C D, NUCERA V, et al. Safety of JAK inhibitors: Focus on cardiovascular and thromboembolic events[J]. Expert Rev Clin Immunol, 2022,18(3): 233-244. doi:10.1080/1744666x.2022.2039630
doi: 10.1080/1744666x.2022.2039630 |
28 |
BELLOSTA S, CORSINI A. Statin drug interactions and related adverse reactions: An update[J]. Expert Opin Drug Saf, 2018,17(1): 25-37. doi:10.1080/14740338.2018.1394455
doi: 10.1080/14740338.2018.1394455 |
29 | BĂLĂNESCU A R, BOJINCĂ V C, BOJINCĂ M. Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases[J]. Exp Ther Med, 2019,17(2): 1024-1029. |
30 |
LIU Y, FANG L, CHEN W, et al. Clinical characteristics, treatment, and outcomes in patients with idiopathic inflammatory myopathy concomitant with heart failure[J]. Int Heart J, 2020,61(5): 1005-1013. doi:10.1536/ihj.19-568
doi: 10.1536/ihj.19-568 |
31 | 彭方琴. 肿瘤标志物CA125与特发性炎症性肌病心血管危险因素及心血管疾病的研究[D]. 泸州:西南医科大学, 2018. |
32 | DIEDERICHSEN L P, DIEDERICHSEN A C, SIMONSEN J A, et al. Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: A Danish multicenter study[J]. Arthritis Care Res (Hoboken), 2015,67(6): 848-854. |
33 |
WELSH P, PREISS D, HAYWARD C, et al. Cardiac troponin T and troponin I in the general population[J]. Circulation, 2019,139(24): 2754-2764. doi:10.1161/circulationaha.118.038529
doi: 10.1161/circulationaha.118.038529 |
34 | BARTH Z, NOMELAND W B, SCHWARTZ T, et al. In juvenile dermatomyositis, heart rate variability is reduced, and associated with both cardiac dysfunction and markers of inflammation: a cross-sectional study median 13.5 years after symptom onset[J]. Rheumatology (Oxford), 2016,55(3): 535-543. |
35 |
QIU M, SUN X, QI X, et al. The diagnostic value of GDF-15 for myocardial involvement in idiopathic inflammatory myopathy[J]. Rheumatology, 2021,60(6): 2826-2833. doi:10.1093/rheumatology/keaa721
doi: 10.1093/rheumatology/keaa721 |
36 |
ZHANG Y, SHAN L, LI D, et al. Identification of key biomarkers associated with immune cells infiltration for myocardial injury in dermatomyositis by integrated bioinformatics analysis[J]. Arthritis Res Ther, 2023,25(1):69. doi:10.1186/s13075-023-03052-4
doi: 10.1186/s13075-023-03052-4 |
37 | 李楠, 康志雷. 3.0T CMR定量技术诊断急性病毒性心肌炎效能及评估短期预后的价值[J]. 实用医学杂志, 2023,39(9): 1169-1173. |
38 |
OLDROYD A G S, LILLEKER J B, AMIN T, et al. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy[J]. Rheumatology, 2022,61(5): 1760-1768. doi:10.1093/rheumatology/keac115
doi: 10.1093/rheumatology/keac115 |
39 | PUJADES-RODRIGUEZ M, MORGAN A W, CUBBON R M, et al. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: A population-based cohort study[J]. PLoS Med, 2020,17(12): e1003432. |
40 | BĂLĂNESCU A R, BOJINCĂ V C, BOJINCĂ M, et al. Cardiovascular effects of methotrexate in immune-mediated inflammatory diseases[J]. Exp Ther Med, 2019,17(2): 1024-1029. |
41 |
van LEUVEN S I, KASTELEIN J J, ALLISON A C, et al. Mycophenolate mofetil (MMF): Firing at the atherosclerotic plaque from different angles?[J]. Cardiovasc Res, 2006,69(2): 341-347. doi:10.1016/j.cardiores.2005.09.018
doi: 10.1016/j.cardiores.2005.09.018 |
42 | ALLANORE Y, VIGNAUX O, ARNAUD L, et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging[J]. Ann Rheum Dis, 2006,65(2): 249-252. |
43 | KOTANI T, MAKINO S, TAKEUCHI T, et al. Early intervention with corticosteroids and cyclosporin A and 2-hour postdose blood concentration monitoring improves the prognosis of acute/subacute interstitial pneumonia in dermatomyositis[J]. J Rheumatol, 2008,35(2): 254-259. |
44 | BECKETT M, TAN J, BONNARDEAUX E, et al. Tofacitinib therapy in refractory inflammatory myositis: A retrospective cohort study of 41 patients[J]. Rheumatology (Oxford), 2024,63(5):1432-1436. |
45 |
LANDON-CARDINAL O, GUILLAUME-JUGNOT P, TOQUET S, et al. JAK inhibitors for the treatment of adult dermatomyositis: A pilot study[J]. J Am Acad Dermatol, 2023,88(4): 924-926. doi:10.1016/j.jaad.2022.10.055
doi: 10.1016/j.jaad.2022.10.055 |
46 |
GRAZZINI S, RIZZO C, CONTICINI E, et al. The role of bDMARDs in idiopathic inflammatory myopathies: A systematic literature review[J]. Autoimmun Rev, 2023,22(2): 103264. doi:10.1016/j.autrev.2022.103264
doi: 10.1016/j.autrev.2022.103264 |
47 |
MCHUGH J. Cancer and cardiovascular risk with JAK inhibition[J]. Nat Rev Rheumatol, 2023,19(2): 64. doi:10.1038/s41584-022-00901-5
doi: 10.1038/s41584-022-00901-5 |
48 |
MATTAY S S, ZAMANI M, SATURNO D, et al. Risk of major adverse cardiovascular events in immune-mediated inflammatory disorders on biologics and small molecules: Network meta-analysis[J]. Clin Gastroenterol Hepatol,2024,22(5):961-970.e12. doi:10.1016/j.cgh.2023.09.033
doi: 10.1016/j.cgh.2023.09.033 |
49 |
OLDROYD A, LILLEKER J B, AMIN T, et al. British society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy[J]. Rheumatology (Oxford), 2022,61(5): 1760-1768. doi:10.1093/rheumatology/keac115
doi: 10.1093/rheumatology/keac115 |
50 |
骆骏骞, 邓志文, 黎土娣, 等. 心力衰竭的治疗进展[J]. 实用医学杂志, 2022,38(10): 1181-1186. doi:10.3969/j.issn.1006-5725.2022.10.002
doi: 10.3969/j.issn.1006-5725.2022.10.002 |
[1] | Qingqing WANG,Jie DING,Haiwen LI,Zhijian DONG,Yiying WANG,Siqi LIU,Guoji CHANG,Lijuan HUA,Huayi CHEN,Shenghao LI,Yongrui. YANG. Analysis of factors influencing short⁃term adverse clinical outcome in cirrhotic patients with grade 2/3 ascites [J]. The Journal of Practical Medicine, 2024, 40(8): 1114-1120. |
[2] | Xiaotong LIU,Xianhua SU,Zhijun XIN,Fengqiong GAO,Jiayi FENG,Tongxia. XIA. Risk factors of postoperative complications in patients with spinal tuberculosis and the predictive value of prognostic nutritional index [J]. The Journal of Practical Medicine, 2024, 40(7): 972-978. |
[3] | Changzhi GUO,Tao SUN,Shuman HAN,Lingxiang WANG,Mengjing. NIU. Risk factors of peripheral infections of knee joint tumor prosthesis and predictive value of serum D⁃dimer and TLR2 [J]. The Journal of Practical Medicine, 2024, 40(6): 814-819. |
[4] | Xilin WANG,Chanjuan YANG,Daomeng. CHENG. Construction of a nomogram prediction model for aggressive behavior in patients with bipolar disorder [J]. The Journal of Practical Medicine, 2024, 40(5): 677-681. |
[5] | Huiqun WANG,Chao YE,Chao XU,Si CHEN,Kaiguang ZHANG,Mei. XIAO. A 5⁃year follow⁃up study of rebleeding after endoscopic treatment of esophageal gastric varices rebleeding associated with liver cirrhosis [J]. The Journal of Practical Medicine, 2024, 40(22): 3155-3159. |
[6] | Shijun LUO,Lizi ZHANG,Dunjin. CHEN. Diagnosis, prevention and treatment of placenta accreta spectrum with non⁃traumatic factors [J]. The Journal of Practical Medicine, 2024, 40(21): 2971-2975. |
[7] | Lili TANG,Xueming LI,Liming LEI,Xiaodong ZENG,Yun LING,Qiongyu LIN,Sumin. ZHU. Risk factors for prolonged ICU stay after surgery in patients with infective endocarditis [J]. The Journal of Practical Medicine, 2024, 40(20): 2854-2859. |
[8] | Jun ZHENG,Qiye WU,Xia ZENG,Zhixian LEI,Dufei. ZHANG. Clinical characteristics and risk factors of the occurrence of hypoxic hepatitis in children with shock [J]. The Journal of Practical Medicine, 2024, 40(15): 2126-2132. |
[9] | Lanrong WANG,Xiaocui WANG,Yang CAO,Rui LI,Weihong WANG,Yingxi XU,Weixiang SHI,Yufei YANG,Ke MENG,Wei. ZHANG. A cross⁃sectional study on the risk of early screening for lung cancer in Zhengzhou City [J]. The Journal of Practical Medicine, 2024, 40(15): 2154-2160. |
[10] | Qian DOU,Yuzhen ZHANG,Yong. ZHOU. EBV infection and influencing factors of nasopharyngeal carcinoma screening population in Guangzhou [J]. The Journal of Practical Medicine, 2024, 40(10): 1440-1444. |
[11] |
WANG Xianfang, LIU Zhidong, ZHANG Yuan, HUANG Changjing, ZHANG Haifei, YU Liqiong, ZHONG Wei..
Association of ABCG2 rs 2231142 and SLC2A9rs 3733591 gene polymorphisms with hyperuricemia in Southern Han population [J]. The Journal of Practical Medicine, 2023, 39(7): 875-880. |
[12] |
JIA Yuanhang, TAN Xiaowu, CHEN Lin, TU Rongfang, ZHOU Fang..
Predictive value of SENP ⁃1/HIF ⁃1α pathway on cardiovascular events in patients with obstructive sleep apnea hypopnea syndrome [J]. The Journal of Practical Medicine, 2023, 39(6): 719-723. |
[13] |
ZU Xiaoyun, JIN Guoxin..
Preliminary exploration of establishing the risk prediction model of nerve injury after thoracolumbar burst fracture in the elderly based on nomogram [J]. The Journal of Practical Medicine, 2023, 39(5): 597-601. |
[14] | Yunyan XU,Can ZHANG,Kaili CHANG,Wei LIU,Qian ZHUO,Shengling LI,Zuyi HE,Hailong. DAI. Progress in diagnosis and treatment of pregnancy complicated with pulmonary arterial hypertension [J]. The Journal of Practical Medicine, 2023, 39(22): 2914-2920. |
[15] | Bin HUANG,Fengkun LU,Xiaorong LI,Zhanhong TANG,Juntao Hu. Analysis of early predictors of severe and critical SARS⁃CoV⁃2 infection [J]. The Journal of Practical Medicine, 2023, 39(21): 2736-2742. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||